Surrozen Inc.

NASDAQ: SRZN · Real-Time Price · USD
9.45
-0.41 (-4.16%)
At close: May 07, 2025, 3:59 PM
10.10
6.93%
After-hours: May 07, 2025, 06:29 PM EDT

Company Description

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration.

It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.

Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts.

Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Surrozen Inc.
Surrozen Inc. logo
Country United States
IPO Date Jan 11, 2021
Industry Biotechnology
Sector Healthcare
Employees 40
CEO Craig C. Parker M.B.A.

Contact Details

Address:
171 Oyster Point Boulevard
South San Francisco, California
United States
Website https://www.surrozen.com

Stock Details

Ticker Symbol SRZN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001824893
CUSIP Number 86889P109
ISIN Number US86889P2083
Employer ID 98-1556622
SIC Code 2836

Key Executives

Name Position
Craig C. Parker M.B.A. Chief Executive Officer, President & Director
Charles Williams Chief Financial Officer, Chief Operating Officer & Corporate Secretary
Dr. Calvin Kuo M.D., Ph.D. Co-Founder & Member of Scientific Advisor
Dr. K. Christopher Garcia Ph.D. Co-Founder & Member of Scientific Advisory Board
Dr. Li Yang Ph.D. Executive Vice President of Research
Dr. Roeland Nusse Ph.D. Co-Founder & Member of Scientific Advisory Board
Esther Jhun Controller

Latest SEC Filings

Date Type Title
May 05, 2025 4 Filing
May 05, 2025 4 Filing
May 05, 2025 4 Filing
May 01, 2025 424B5 Filing
Apr 24, 2025 424B5 Filing
Apr 23, 2025 S-3 Filing
Apr 08, 2025 D Filing
Apr 02, 2025 SCHEDULE 13G Filing
Apr 02, 2025 ARS Filing
Apr 02, 2025 SCHEDULE 13G Filing